Harrow Health (HROW) Misses Q4 EPS by 23c

Harrow Health (NASDAQ: HROW) reported Q4 EPS of ($0.27), $0.23 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $19.35 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49